Skyrizi: How long it takes to work

Skyrizi is used to treat certain inflammatory conditions, such as plaque psoriasis. The drug starts working after your first dose.

The Food and Drug Administration (FDA) has approved Skyrizi to treat the following conditions in certain adults:

Skyrizi helps reduce inflammation and ease symptoms of these conditions. Learn more about how long Skyrizi takes to start working, how effective the drug is, and how long it stays in your system.

Skyrizi starts working after your first dose. Your doctor may prescribe a starting dose and a maintenance (ongoing) dose for Skyrizi, depending on the condition being treated. They will monitor you while receiving Skyrizi to check whether the drug is working to treat your condition.

How soon you begin to feel or see your symptoms easing may depend on the condition being treated.

For example, when using Skyrizi for Crohn’s disease, you may start to experience less abdominal pain and fewer bowel movements after 4 weeks of treatment. When using Skyrizi for plaque psoriasis, you may begin to see significant reduction in symptoms such as pain, burning, and itching at about 16 weeks of treatment.

How it works

Skyrizi is used to treat certain inflammatory conditions, such as plaque psoriasis. These conditions can cause your immune system to mistakenly attack healthy areas of your body, leading to inflammation. This inflammation can affect your skin, digestive system, and joints.

Skyrizi is part of a drug class called interleukin-23 (IL-23) inhibitors. It works by attaching to IL-23, a protein that may play a role in inflammation. By attaching to IL-23, Skyrizi helps reduce inflammation and ease symptoms of these conditions.

The drug manufacturer’s website provides more details about how Skyrizi works for each of its uses:

How long does Skyrizi stay in your system?

The half-life of Skyrizi is about 28 days when it’s used for plaque psoriasis and 21 days when it’s used for Crohn’s disease. It typically takes about Skyrizi is an effective treatment option for plaque psoriasis, Crohn’s disease, ulcerative colitis, and psoriatic arthritis. Success rates may vary depending on the condition being treated and individual factors, such as any other health conditions you have. For example, in clinical trials, 73% of people using Skyrizi for plaque psoriasis saw 90% clearer skin at 16 weeks of treatment. Most of those people continued to see 90% clearer skin at 12 months. Also, more than half of people using Skyrizi for psoriatic arthritis in clinical trials reported at least a 20% improvement in symptoms such as joint pain and stiffness after 24 weeks of treatment. If you have questions about Skyrizi’s effectiveness, talk with your doctor or pharmacist. Skyrizi is used to treat certain inflammatory conditions, such as plaque psoriasis and Crohn’s disease. The drug begins to work after your first dose, but the amount of time it takes for you to notice symptom relief may depend on the condition you’re using Skyrizi to treat. Talk with your doctor or pharmacist if you have additional questions about Skyrizi. Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.